Barchart.com
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.56 -0.07 (-1.93%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.57 +0.01 (+0.28%) 19:59 ET
News & Headlines for Fri, Mar 28th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Traws Pharma Announces Management Updates GlobeNewswire - Fri Mar 28, 3:30PM CDT

TRAW : 2.40 (-6.61%)
IOVA : 3.56 (-1.93%)
IKNA : 1.3200 (-0.75%)
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street Motley Fool - Sat Mar 22, 12:56PM CDT

Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines. Though the company reached a significant milestone last year -- with regulatory approval...

IOVA : 3.56 (-1.93%)
3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not Motley Fool - Sat Mar 22, 10:05AM CDT

The time to buy quality prospects is when the rest of the market is ignoring their value.

IOVA : 3.56 (-1.93%)
PEP : 149.27 (-0.27%)
SIRI : 22.75 (-4.49%)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Fri Mar 21, 4:15PM CDT

IOVA : 3.56 (-1.93%)
Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up? Motley Fool - Wed Mar 12, 9:15AM CDT

When a stock is in a freefall, there's usually a justifiable reason for the decline. But for investors with a high risk tolerance, it could make for a potentially attractive contrarian play. A stock that...

IOVA : 3.56 (-1.93%)
Iovance Biotherapeutics: Q4 Earnings Snapshot AP - Thu Feb 27, 3:29PM CST

Iovance Biotherapeutics: Q4 Earnings Snapshot

IOVA : 3.56 (-1.93%)
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024 GlobeNewswire - Thu Feb 27, 3:01PM CST

IOVA : 3.56 (-1.93%)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Fri Feb 21, 4:15PM CST

IOVA : 3.56 (-1.93%)
My 3 Favorite Stocks to Buy Right Now Motley Fool - Thu Feb 20, 6:30AM CST

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

IOVA : 3.56 (-1.93%)
AXON : 534.95 (-2.85%)
UBER : 72.75 (-2.82%)
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025 GlobeNewswire - Tue Feb 18, 3:01PM CST

IOVA : 3.56 (-1.93%)

Barchart Exclusives

Trump Tariffs, Tesla Deliveries and Other Key Things to Watch this Week Barchart - Sun Mar 30, 6:38PM CDT
The S&P 500 suffered more selling on Friday after a hot inflation report and weak consumer sentiment spooked investors. Here are 5 things to watch this week in the Market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot